More on RCUS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)
- Holders

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Arcus Biosciences (NY:RCUS)
Delayed: 23.86 -0.61 (2.49%)
Prev. Close $24.47  
Open$24.62 
52 Wk High$ 
52 Wk Low$ 
Day High$24.83 
Day Low$23.54 
P/E N/A  
EPS$ 
Volume956,647 


Jun 3, 2026 08:01 AM Arcus Biosciences partners with Bristol Myers Squibb on kidney cancer trial
Jun 3, 2026 08:00 AM Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer
Jun 1, 2026 07:24 PM Form 4 Arcus Biosciences, Inc. For: Jun 01 Filed by: Azoy Alexander
Jun 1, 2026 04:26 PM Form 144 Arcus Biosciences, Inc. Filed by: Azoy Alexander
May 26, 2026 04:05 PM Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 18, 2026 06:21 AM Truist Securities Assumes Arcus Biosciences (RCUS) at Buy
May 12, 2026 04:09 PM Form 4 Arcus Biosciences, Inc. For: Dec 16 Filed by: Ribas Antoni
May 12, 2026 04:09 PM Form 4 Arcus Biosciences, Inc. For: May 11 Filed by: Goeltz II Robert C.
May 11, 2026 05:34 PM Form 144 Arcus Biosciences, Inc. Filed by: Goeltz II Robert C.
May 11, 2026 08:26 AM Arcus Biosciences (RCUS) PT Raised to $22 at Morgan Stanley
View All Articles

Entities mentioned with RCUS

View All Entities